glp-1 drugs manufacturers top glp 1 drug companies Analogues Transform Metabolic Disease Management Puerto Rico leads U.S. growth

Providers can use the GLP-1 Supply Tracker to stay informed about supply so that they can best counsel their patients on the most clinically appropriate and reliably available GLP-1 treatment, said Dr

Discontinuing glucagonlike peptide-1 receptor agonists and body habitus: A systematic review and meta-analysis

In the same 2025 study by Qeadan and colleagues, individuals with a history of opioid use disorder (n=503,747) prescribed GLP-1 medications had about a 40% lower rate of opioid overdose events during the 2-year follow-up period (Qeadan et al., 2025)

The overlapping indication creates efficiency

Clinicians should therefore remain alert to emerging updates and apply flexible, evidence-based approaches

Drucker the 2020 Warren Alpert Foundation Prize